Logo Geneseeq
  • Services
    • Genomic Testing
      • Companion Diagnostic Test
      • Laboratory Developed Tests (LDT)
        • Solid Tumors
        • Hematologic Malignancies
        • Hereditary Cancers
        • Minimal Residual Disease
    • Research Services
      • Platforms
      • DNA Sequencing
      • RNA Sequencing
      • Other Services
  • Technology
    • Our Technology
    • Publications
  • Partnerships
  • About Us
    • What is Precision Oncology?
    • Our Company
    • Our Team
    • Certificates & Accreditation
  • News
  • Join Us
  • Contact Us
  • Ch|中文
  • Search

November 15, 2022

Geneseeq Publishes Promising Early Lung Cancer Detection Results in AJRCCM


by Geneseeq

August 3, 2022

GENESEEQ AND COLLABORATORS SHARE NEW FINDINGS AT WORLD CONFERENCE ON LUNG CANCER 2022


by Geneseeq

July 19, 2022

Geneseeq, Brazilian Hospital Partner on Co-establishment of In-house NGS Lab


by Geneseeq

April 5, 2022

Geneseeq Presents 9 Posters at AACR 2022


by Geneseeq

November 22, 2021

Geneseeq announces new publication utilizing ultradeep sequencing technology Automated TTriple Groom sequencing (ATG-seq) to monitor minimal residual disease in postoperative non-small cell lung cancer


by Geneseeq

November 11, 2021

Geneseeq Forms Lung Cancer Strategic Partnerships with Takeda and AstraZeneca on the Same Day


by Geneseeq

September 8, 2021

Geneseeq Presents ctDNA Early Lung Cancer Detection Data at WCLC


by Geneseeq

June 17, 2021

Geneseeq Joins Integrated DNA Technologies (IDT) Align Program


by Geneseeq

March 19, 2021

Lung cancer genomic study reveals timing and origins of local and distant metastases and highlights the importance of early cancer detection


by Geneseeq

June 2, 2020

Geneseeq to showcase novel translational research at the 2020 AACR Virtual Annual Meeting II


by Lucy

  • 1
  • 2
Logo Geneseeq

1-647-255-1076
1-800-362-0325
info.toronto@geneseeq.com

Quick Links
  • Services
  • Technology
  • News
  • About Us
Connect
  • Partnerships
  • Join us
  • Contact us
Privacy
  • Privacy Policy
  • Terms of Use
Headquarters

101 College Street
Suite 200, MaRS Centre
South Tower
Toronto, Ontario, M5G 1L7
Canada

© 2023 Geneseeq Technology Inc. | A Precision Oncology Company. All rights reserved

Privacy Preference Center

Privacy Preferences